Quote:
Originally Posted by Riverwild
Not sure why the above business article was posted.
As for the generation of profits, there are agreements in place where for every certain number of patients on Tysabri, Biogen must pay Elan a royalty above the normal profit share.
I could elaborate on this but this thread is for Tysabri users for information and questions about using Tysabri, not a business thread, so I will refrain.
|
The reason this matters to Vic (and others), is that he no longer able to take this med because of COST, and the continuously growing cost of the med and/or infusion center charges is very relevant for many people who are on or are wanting this drug.
Most of the “news” in that article was very good (at least that’s the way I saw it), but it was COST factor that I was posting to. Vic had brought up that 43 out of the 48 patients had to stop taking this drug because of infusion costs, and this article suggests that for every 10,000 people on Tysabri, the company generates 100,000 million in profit (NOTE: not revenue, but PROFIT).
I didn’t realize that this was something we shouldn’t be talking about here, so I will seek more clearly defined parameters for this thread with the administration.
Cherie
__________________
I am not a Neurologist, Physician, Nurse, or Hairdresser ... but I have learned that it is not such a great idea to give oneself a haircut after three margaritas
.